Increased sFlt-1 concentrations bind circulating PlGF and vascular endothelial growth factor (VEGF), blocking their endothelial cell receptor interactions and triggering endothelial dysfunction [12,13]. This evidence concerns the gene VEGFA and endothelial dysfunction.